Global Markets And Technologies For Advanced Drug Delivery Systems
NEW YORK, Jan. 23, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Global Markets and Technologies for Advanced Drug Delivery Systems http://www.reportlinker.com/p01940407/Global-Markets-and-Technologies-for-Advanced-Drug-Delivery-Systems.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Delivery_Technology
STUDY OBJECTIVESA drug delivery system is one of the very important aspects in today's growth in the pharmaceutical industry. BCC Research's goal in steering this study is to provide an overview of the current and future characteristics of the market for these drug delivery systems. The key objective is to present a comprehensive analysis and future direction of these drug delivery systems as an important tool in improving the efficacy and safety of the release of drugs in the body.This report explores the present and future strategies within the drug delivery market, which includes sustained release drug delivery, prodrug, implants and intrauterine devices (IUDs), targeted drug delivery, polymeric drug delivery, transdermal drug delivery, and transmucosal drug delivery systems. The improvisation of the market and the setbacks and the needs of the market are discussed in this report. The classifications, comparisons and usage of these types of drug delivery systems are also portrayed in this report.A detailed analysis of drug delivery industry structure has been conducted. Revenues are broken down by region. Sales figures are estimated for the five-year period from 2013 through 2018.Applications for drug delivery systems are also discussed in the report, with emphasis on the usage of these systems in various therapeutic categories and various disease sectors. The report also covers significant patents and their allotments in each category.
REASONS FOR DOING THIS STUDYExtensive research in the field of various drug delivery systems has revealed their specific functionality in improving the transportation of a pharmaceutical compound in the body as desired to safely achieve its anticipated therapeutic effect. Modern industries have now begun to explore the advantages of these drug delivery systems in their productions and processes. This has led to the steady market for those drug delivery systems.R&D spending, along with increasing competition, patent expiries and new technologies, are directing this in a new direction. The new advancements and new product launches have influenced the market to grow in the foreseeable future. This study looks at almost all the systems affected by these factors.Acquisition strategies and collaborations by companies are also covered in this report. This study also discusses the strengths and weaknesses of each type/technology in light of the new technologies, growing competition and changing customer needs.INTENDED AUDIENCEThis study contributes to the areas of market growth in various drug delivery systems manufacturers and users. Pharmaceutical biotechnical companies and research institutes will find this study to be of interest. SCOPE OF THE STUDYThe scope of this study encompasses drug delivery systems in pharmaceutical and biotechnology markets. BCC Research analyzes each market by its type, region and its applications, regulatory environment, technology, market projections and market share. Technological issues include the latest trends and developments. The emerging markets for drug delivery systems include countries such as India, China, Japan, Korea, Taiwan, Canada, Africa, Australia, New Zealand and so forth. METHODOLOGYBoth primary and secondary research methodologies were used in preparing this study. BCC Research conducted a comprehensive literature search, which included technical newsletters and journals, and many other sources. Data were collected through interviews and correspondence with manufacturers of drug delivery systems and technical experts. Projections were based on estimates such as the current number of end users, potential end users, mergers and acquisitions, new developments and market trends. INFORMATION SOURCESMany companies were surveyed to obtain data for this study. Included were manufacturers and end users of drug delivery systems in therapeutic categories and various disease sectors industries. Data were gathered from various industry sources. BCC Research spoke with officials within the industry, consulted newsletters, company literature, product literature, and a host of technical articles, journals, indexes and abstracts. Exhaustive investigations of databases by key terminology were completed. In addition, data were compiled from current financial, trade and government sources. ABOUT THE AUTHORA team of professionals in the biotechnology industry carried out this study. The project manager is Shalini S. Dewan, who holds a master's degree in pharmaceutical chemistry and has over 14 years' of industry experience. Among the research topics she has covered are studies on compounds of potential pharmaceutical interest from ibuprofen and 2-naphthyl acetic acid. Shalini was awarded a Gold Medal by the Prime Minister of India for her work and has worked with top companies in India and in the U.S. Some of her other reports with BCC Research are: Reagents for Chromatography; Spectroscopy: An Enduring Market; Advanced Drug Delivery Systems: Technologies and Global Markets; Orthopedic Drugs, Implants and Devices; Medical Imaging Reagents and Analysis Equipment; Pharmaceutical Regulatory Industry; The Dynamic Media, Sera and Reagent Market in Biotechnology; Contract Pharmaceutical Manufacturing, Research and Packaging: Global Markets; Chiral Technology: Global Markets; Autacoids and Related Drugs: Technologies and Global Markets; Contraceptives: Technologies and Global Markets; Liver Disease Treatments: The Global Market; Hormone Replacement Therapies and Other Hormone Therapies: Global Markets; Cardiovascular Medicine: Diagnostics, Drugs and Devices; and Cancer Therapies: Technologies and Global Markets. REPORT HIGHLIGHTSThe global revenue for advanced drug delivery systems is estimated to be $181.9 billion in 2013. In 2018, revenues are estimated to reach $212.8 billion, demonstrating a compound annual growth rate (CAGR) of 3.2%.This report provides:• An overview of the global market for drug delivery systems, including the market as seen by the end users of the different applications.• Analyses of global market trends, with data from 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018.• Discussion of the current state, setbacks, innovations, and the future needs of the market.• Examination of the different categories of drug delivery, broken down by market shares of the leading manufacturers and/or suppliers, as well as acquisitions, mergers, and alliances by companies and global organizations.• Analyses of the regulatory environment, and the technology involved, including the latest trends and developments. TABLE OF CONTENTS CHAPTER 1 INTRODUCTION 2STUDY OBJECTIVES 2REASONS FOR DOING THIS STUDY 2INTENDED AUDIENCE 3SCOPE OF THE STUDY 3METHODOLOGY 3INFORMATION SOURCES 3ABOUT THE AUTHOR 3RELATED BCC RESEARCH REPORTS 4BCC RESEARCH ONLINE SERVICES 4DISCLAIMER 4 CHAPTER 2 SUMMARY 6SUMMARY TABLE GLOBAL REVENUE OF ADVANCED DRUG DELIVERY SYSTEMS,BYREGION, THROUGH 2018 ($ MILLIONS) 7SUMMARY FIGURE GLOBAL REVENUE OF ADVANCED DRUG DELIVERY SYSTEMS,BYREGION, 2011-2018 ($ MILLIONS) 7 CHAPTER 3 OVERVIEW 9NEED FOR THE DOSAGE FORMS 9TABLE 1 HISTORIC EVENTS IN DRUG DELIVERY 10CLASSIFICATION OF DRUG DELIVERY ACCORDING TO TECHNOLOGY 11SUSTAINED RELEASE DRUG DELIVERY 11Oral Sustained Release Drug Delivery 11Intramuscular (IM) Injections or Microsyringes 12TABLE 2 ADVANTAGES AND DISADVANTAGES OF SUSTAINED RELEASE DRUGDELIVERY 12PRODRUGS 13Subtypes of Prodrugs 14TABLE 3 CLASSIFICATION OF PRODRUGS 14Need for Prodrugs 15TABLE 4 ADVANTAGES AND DISADVANTAGES OF PRODRUGS 15IMPLANTS AND INTRAUTERINE DEVICES (IUDS) 16Copper-based Devices 16Hormonal-based Devices 16Mechanism 17TABLE 5 ADVANTAGES AND DISADVANTAGES OF IMPLANTS AND IUDS 17TARGETED DRUG DELIVERY 18Delivery Vehicles 18Liposomes 18TABLE 6 ADVANTAGES AND DISADVANTAGES OF LIPOSOMES 19Micelles and Dendrimers 19 Mechanisms of Drug Delivery 19Advantages of Dendrimers 20Biodegradable Particles 20Artificial DNA Nanostructures 20Monoclonal Antibodies 21Applications 21TABLE 7 ADVANTAGES AND DISADVANTAGES OF MONOCLONAL ANTIBODIES 22POLYMERIC DRUG DELIVERY 22Applications of Polymers in Drug Delivery 22TABLE 8 ADVANTAGES AND DISADVANTAGES OF POLYMERS 23Pegylation 23TABLE 9 ADVANTAGES AND DISADVANTAGES OF PEGYLATION 24Future Perspectives 24CLASSIFICATION OF DRUG DELIVERY BY ROUTE OF ADMINISTRATION 24ORAL DRUG DELIVERY 24TABLE 10 ADVANTAGES AND DISADVANTAGES OF ORAL DRUG DELIVERY 25INJECTABLE OR PARENTERAL DRUG DELIVERY 25TABLE 11 ADVANTAGES AND DISADVANTAGES OF PARENTRAL DRUG DELIVERY 25PULMONARY DRUG DELIVERY 26TABLE 12 ADVANTAGES AND DISADVANTAGES OF PULMONARY DRUG DELIVERY 26NASAL DRUG DELIVERY 27
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts